Alaros Exploration Inc. Announces Record Date for Share Split
Alaros Exploration Inc. has officially set October 29, 2026, as the record date for its upcoming share split.
Stocks · News reference
Why Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Atkore Inc (ATKR) shares rise on strong Q3 results and acquisition by Prysmian for $95.00 per share. Other gainers include UPC, YYAI, RITR, FCUV, SGLY, FNGR, ALAR, FERG, and BMY while FMFC, PWCM, SITC, JDZG, and MGRX are among the losers.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Kirby McInerney LLP Alerts Investors Who Acquired Alibaba Group Holding Limited BABA Securities Between June 26, 2025 and June 24, 2026 of Pending Lawsuit
Law firm Kirby McInerney LLP announced pending securities class action lawsuits against Alibaba Group Holding Limited, Taboola.com Ltd., and Alarum Technologies Ltd. The Alibaba lawsuit alleges the company made false statements regarding its control by China's Ministry of Industry and Information Technology and engaged in unauthorized AI model distillation attacks. Stock prices declined significantly following disclosure of these issues in June 2026. Investors have until specified deadlines in October 2026 to seek lead plaintiff status.
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026
Alvotech announced it will release its financial results for the nine months and third quarter ended September 30, 2026, on November 11, 2026.
Alvotech birtir uppgjör fyrstu níu mánaða ársins 2026 þann 11. nóvember nk.
Alvotech announced it will release its nine-month financial results for 2026 on November 11, with a live webcast presentation scheduled for November 12. The company also received FDA approval for an enhanced SIMLANDI® manufacturing process that more than doubles output per batch, increasing manufacturing productivity and freeing capacity to support growing demand across its biosimilars portfolio.
Alvotech shares are trading higher after the company announced FDA approval for a new manufacturing process for SIMLANDI.
FDA Approves Alvotech’s Process 2.0 For SIMLANDI Drug Substance, More Than Doubling Output Per Batch Without Changing Upstream Manufacturing Scale